Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
prolonging spray.
Popular Articles

U.S. Food And Drug Administration Approves ONGLYZA™ (saxagliptin) For The Treatment Of Type 2 Diabetes Mellitus In Adults
Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) announced that the U.S. Food and Drug Administration (FDA) approved ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor. ONGLYZA is indicated as an adjunct to diet and exercise to improve blood sugar (glycemic) control in adults for the treatment of type 2 diabetes mellitus. ONGLYZA once daily can be used in combination with commonly prescribed oral anti-diabetic medications metformin, sulfonylureas or thiazolidinediones (TZD) or as a monotherapy to significantly reduce glycosylated hemoglobin (A1C) levels. ONGLYZA should not be used for the treatment of type 1 diabetes or for the treatment of diabetic ketoacidosis (high levels of certain acids, known as ketones, in the blood or urine). ONGLYZA has not been studied in combination with insulin.
generic viagra
In Trastuzumab-Resistant Metastatic Breast Cancer, Small Molecule Inhibitor Shows Promise
Fox Chase Cancer Center researchers report that a combination of trastuzumab and neratinib (HKI-272) a novel small molecule inhibitor of the HER2 receptor (ErbB2) appears active in women with HER2-positive metastatic breast cancer who have progressed on previous trastuzumab based therapies. More than one-quarter of the women in a phase I/II trial had their tumors shrink on the combination therapy.
Zubni implantati
News of the day
Forsyth Medical Center Participating In Avastin Trial For New Glioblastoma Patients
The Derrick L. Davis Forsyth Regional Cancer Center at Forsyth Medical Center is participating in a national trial of the experimental drug Avastin to treat glioblastoma, a fast-growing tumor of the brain or spinal cord.
Diagnostics

Diabetes Educators Get First Taste Of Nevella(R) With Probiotics, The Only Sweetener Designed To Boost The Immune System

Designed to boost the immune system and promote health, probiotics are gaining popularity at the grocery, and Nevella® with Probiotics, made by Heartland Sweeteners, is the first and only such sweetener currently on the market. Diabetes educators will get an early preview of Nevella® with Probiotics at their annual conference in Atlanta in early August, immediately prior to widespread availability across the country. "We wanted to give the American Association of Diabetes Educators a first look at Nevella® with Probiotics, since people with diabetes know the importance of maintaining a healthy weight and controlling blood sugar, and no-calorie sweeteners can help with that," said Mike Servie, President of Heartland Sweeteners. "Probiotics also show promise for enhancing the immune system, which is important for those with type 1 diabetes." Unlike other foods enhanced with probiotics, the GanedenBC30® probiotic used in Nevella® is shelf stable, and survives the digestive process to arrive in your gut where you need it. A single sachet of Nevella with Probiotics delivers greater efficacy than most other probiotics, including a cup of yogurt. Ganeden BC30 withstands baking temperatures better than other probiotics, so now consumers can add probiotic benefits to their favorite baked goods. Nevella® with Probiotics is available in 50-count, 100-count and 200-count packets, as well as 9.7-ounce recloseable bags perfect for baking. Major retailers such as Food Lion, A & P, Bi-Lo, HEB, Piggly Wiggly, Meijer and Dollar General will stock the sweetener beginning in late August. Heartland Sweeteners


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009